JP2019182863A - Skin firmness or moisture improving composition - Google Patents
Skin firmness or moisture improving composition Download PDFInfo
- Publication number
- JP2019182863A JP2019182863A JP2019075395A JP2019075395A JP2019182863A JP 2019182863 A JP2019182863 A JP 2019182863A JP 2019075395 A JP2019075395 A JP 2019075395A JP 2019075395 A JP2019075395 A JP 2019075395A JP 2019182863 A JP2019182863 A JP 2019182863A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- composition
- skin firmness
- water
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 230000037393 skin firmness Effects 0.000 title claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 89
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 102000029816 Collagenase Human genes 0.000 claims abstract description 21
- 108060005980 Collagenase Proteins 0.000 claims abstract description 21
- 229960002424 collagenase Drugs 0.000 claims abstract description 21
- 102000016387 Pancreatic elastase Human genes 0.000 claims abstract description 18
- 108010067372 Pancreatic elastase Proteins 0.000 claims abstract description 18
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 15
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 4
- 241000501667 Etroplus Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 abstract description 11
- 241000546273 Lindera <angiosperm> Species 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 8
- 239000000419 plant extract Substances 0.000 abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 76
- 239000000843 powder Substances 0.000 description 29
- 238000000605 extraction Methods 0.000 description 27
- 238000002360 preparation method Methods 0.000 description 22
- 238000012360 testing method Methods 0.000 description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 239000000523 sample Substances 0.000 description 11
- 241000604893 Lindera umbellata Species 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- -1 aliphatic alcohols Chemical class 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 238000005520 cutting process Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000723346 Cinnamomum camphora Species 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000003149 assay kit Methods 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 235000013736 caramel Nutrition 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002849 elastaseinhibitory effect Effects 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000008717 functional decline Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 102000004201 Ceramidases Human genes 0.000 description 1
- 108090000751 Ceramidases Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000245109 Lindera glauca Species 0.000 description 1
- 235000001577 Lindera glauca Nutrition 0.000 description 1
- 240000006370 Lindera obtusiloba Species 0.000 description 1
- 235000012857 Lindera obtusiloba Nutrition 0.000 description 1
- 241000193317 Lindra <fungus> Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940124410 anti-helicobacter pylori agent Drugs 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002683 reaction inhibitor Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019685 rice crackers Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
- Confectionery (AREA)
- Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Dairy Products (AREA)
Abstract
Description
本発明は、天然植物素材を有効成分として含有する、肌のハリ又はうるおいの改善用組成物に関する。 The present invention relates to a composition for improving skin firmness or moisture containing a natural plant material as an active ingredient.
クスノキ科植物のクロモジは北海道の南部から九州まで広く分布している落葉低木であり、その枝葉は烏樟(うしょう)と呼ばれ、古くから消化器系を助ける生薬や民間薬の原料として用いられてきた。また、良い香りがあるのが特徴で、和菓子に添える高級爪楊枝や、水蒸気蒸留して採取した精油がアロマなどに利用されている。 The camphor tree is a deciduous shrub that is widely distributed from the southern part of Hokkaido to Kyushu. Its branches and leaves are called coral and have long been used as a raw material for herbal medicines and folk medicines that help the digestive system. Has been. In addition, it has a good fragrance, and high-grade toothpicks to be added to Japanese sweets and essential oils collected by steam distillation are used for aroma.
従来、このクロモジには、種々の機能性が報告されている。例えば、特許文献1には、クスノキ科クロモジ樹皮の抽出物からなるメラニン産生抑制剤が記載されている。また、特許文献2には、クロモジ等の植物の抽出物を有効成分とする抗ヘリコバクター・ピロリ剤が記載されている。また、特許文献3には、クロモジ等のクスノキ科の植物の一部位の粉砕物またはその脂溶性溶媒抽出エキスを含有するアルコール障害予防剤が記載されている。また、特許文献4には、クロモジ属(Lindera Thunb.)に属する植物の抽出物を有効成分とするプロテアーゼ阻害剤が記載されている。また、特許文献5には、クロモジ等のクスノキ科植物の水蒸気蒸留水を含有することを特徴とする化粧料組成物が記載されている。また、特許文献6には、クロモジ等の植物の抽出物を有効成分とする抗インフルエンザウイルス剤が記載されている。また、特許文献7には、クロモジ等の植物又はそのエキスを含有することを特徴とする血圧降下剤が記載されている。また、特許文献8には、クロモジ等の植物エキスを有効成分として含有するメイラード反応阻害剤が記載されている。また、特許文献9には、クロモジ等の植物の処理物を含有することを特徴とするIgE産生抑制組成物及び抗アレルギー組成物が記載されている。また、特許文献10には、クロモジ等の植物の抽出物を有効成分として含有することを特徴とするセラミダーゼ活性阻害剤が記載されている。 In the past, various functionalities have been reported for this black moji. For example, Patent Document 1 describes a melanin production inhibitor composed of an extract of the camphor tree barkwood bark. Patent Document 2 describes an anti-Helicobacter pylori agent containing a plant extract such as black moji as an active ingredient. Patent Document 3 describes an alcohol disorder preventive agent containing a pulverized product of one part of a camphor family such as black moji or a fat-soluble solvent extract thereof. Patent Document 4 describes a protease inhibitor containing, as an active ingredient, an extract of a plant belonging to the genus Lindera Thunb. Patent Document 5 describes a cosmetic composition characterized by containing steam distilled water of a camphor family such as black moji. Patent Document 6 describes an anti-influenza virus agent containing a plant extract such as black moji as an active ingredient. Patent Document 7 describes an antihypertensive agent characterized by containing a plant such as black moji or an extract thereof. Patent Document 8 describes a Maillard reaction inhibitor containing a plant extract such as black moji as an active ingredient. Patent Document 9 describes an IgE production-suppressing composition and an antiallergic composition characterized by containing a processed product of a plant such as black moji. Patent Document 10 describes a ceramidase activity inhibitor characterized by containing a plant extract such as black moji as an active ingredient.
本発明の目的は、天然植物素材を用いて、優れた機能性を有する組成物を提供することにある。 An object of the present invention is to provide a composition having excellent functionality using a natural plant material.
本発明者らは、上記目的を達成するため鋭意研究した結果、クスノキ科植物のクロモジから抽出したクロモジエキスには、コラゲナーゼやエラスターゼの阻害作用があることを見出し、本発明を完成するに至った。 As a result of intensive studies to achieve the above-mentioned object, the present inventors have found that a chromophore extract extracted from a camphoraceae chromophore has an inhibitory action on collagenase and elastase, and completed the present invention. .
すなわち、本発明は、第1には、クロモジエキスを有効成分として含有することを特徴とする肌のハリ又はうるおいの改善用組成物を提供するものである。 That is, the present invention firstly provides a composition for improving the firmness or moisture of the skin, characterized by containing chromomy extract as an active ingredient.
上記肌のハリ又はうるおいの改善用組成物においては、前記クロモジエキスは、コラゲナーゼ及びエラスターゼの阻害作用を有するものであることが好ましい。 In the above-mentioned composition for improving skin firmness or moisture, it is preferable that the chromomy extract has an inhibitory action on collagenase and elastase.
また、上記肌のハリ又はうるおいの改善用組成物においては、前記クロモジエキスは、クロモジの水、有機溶媒、又は含水の有機溶媒による抽出物を含むものであることが好ましい。 Moreover, in the above-mentioned composition for improving skin firmness or moisture, it is preferable that the chromomy extract contains an extract of chromomy water, an organic solvent, or a water-containing organic solvent.
また、上記肌のハリ又はうるおいの改善用組成物においては、前記クロモジエキスは、クロモジの熱水、低級脂肪族アルコール、又は含水の低級脂肪族アルコールによる抽出物を含むものであることが好ましい。 In the composition for improving the firmness or moisture of the skin, it is preferable that the chromody extract contains an extract of chromody with hot water, a lower aliphatic alcohol, or a hydrous lower aliphatic alcohol.
また、上記肌のハリ又はうるおいの改善用組成物においては、該組成物は、外用であることが好ましい。 In the above-mentioned composition for improving skin firmness or moisture, the composition is preferably used externally.
本発明によれば、クスノキ科植物のクロモジから抽出したクロモジエキスには、コラゲナーゼやエラスターゼの阻害作用があることが明らかとなった。これにより、そのクロモジエキスを有効成分にして、優れた機能性を有する、肌のハリ又はうるおいの改善用組成物を提供することができる。また、その組成物は、化粧品等の外用の利用形態にも適している。 According to the present invention, it has been clarified that a chromophore extract extracted from a camphoraceae plant has an inhibitory action on collagenase and elastase. Thereby, it is possible to provide a composition for improving skin firmness or moisture having excellent functionality, using the chromophore extract as an active ingredient. The composition is also suitable for external use forms such as cosmetics.
本発明は、クスノキ科植物のクロモジから抽出したクロモジエキスには、コラゲナーゼやエラスターゼの阻害作用があることを見出し、これに基づき、肌のハリ又はうるおいの改善用組成物を提供するものである。すなわち、例えば、コラゲナーゼによるコラーゲンの減少、機能低下などを抑制し、また、エラスターゼによるエラスチンの減少、機能低下などを抑制し、肌のハリ又はうるおいの改善作用を発揮させるものである。よって、ヒトや動物の生体に作用する機能性を備えた組成物を提供するものであり、以下では、説明の便宜のために「機能性組成物」あるいは単に「組成物」という場合がある。 The present invention has been found that a chromophore extract extracted from a camphoraceae of a camphoraceae plant has an inhibitory action on collagenase and elastase, and based on this, a composition for improving skin firmness or moisture is provided. That is, for example, collagen reduction and functional decline caused by collagenase are suppressed, and elastin reduction and functional decline caused by elastase are suppressed to exert an effect of improving skin firmness or moisture. Therefore, the present invention provides a composition having functionality that acts on a living body of a human being or an animal, and hereinafter, it may be referred to as “functional composition” or simply “composition” for convenience of explanation.
本発明に用いられるクロモジエキスの基原としては、クロモジ属(Lindera)に属する植物であればよく、例えば、クロモジ(Lindera umbellata Thunb.)、オオバクロモジ(Lindera umbellata var. membranacea (Maxim.) Momiyam)、ヒメクロモジ(Lindera umbellata var.lancea Momjyama)、ケクロモジ(Lindera sericea(Sieb.et Zucc.)Blume)、ウスゲクロモジ(Lindera sericea var.glabrata Blume)、シロモジ(Lindera triloba(Sieb.et Zucc.)Blume)、アメリカクロモジ(Lindera benzoin(L.)Blume)、ヤマコウバシ(Lindera glauca Blume)、ダンコウバイ(Lindera obtusiloba Blume)、テンダイウヤク(Lindera strychnifolia(Sieb.et Zucc.)F.Vill.)などが挙げられる。これらの中でも、特に、クロモジ(Lindera umbellata Thunb.)が好ましい。 The base of the black moji extract used in the present invention may be a plant belonging to the genus Lindera, for example, black moji (Lindera umbellata Thunb.), Psyllium umbellata var. Membranacea (Maxim.) Momi. , S. cerevisiae (Lindera umbellata var. Kurodaji (Lindera benz) oin (L.) Blume), Yamadae Bee (Lindera glauca Blume), Dankobai (Lindra obtusiloba Blume), Tendai Yaku (Lindera strechnifolia (Sieb. et Zucc.) F. and others. Among these, Kuromoji (Lindera umbellata Thunb.) Is particularly preferable.
上記植物の部位としては、特に制限はなく、例えば、幹枝、幹、枝葉、葉、樹皮、根、根茎、根皮、茎、花、種子、果皮、果肉、果実、地上部、地下部、全木などが挙げられる。これらの中でも、特に、幹枝が好ましい。 The part of the plant is not particularly limited, and examples thereof include trunks, trunks, branches and leaves, leaves, bark, roots, rhizomes, root barks, stems, flowers, seeds, pericarp, flesh, fruits, above-ground parts, underground parts, all Examples include trees. Among these, a trunk branch is particularly preferable.
本発明においては、上記植物を基原として抽出物を調製して、それを有効成分として用いる。より具体的には、クロモジの抽出物たるクロモジエキスを、上記した機能性の関与成分として用いるものである。その抽出に用いられる抽出溶媒としては、適宜適当な溶媒を用いればよいが、典型的には水、有機溶媒、又は含水の有機溶媒が挙げられる。有機溶媒としては、特には、例えば、メタノール、エタノール、1,3−ブチレングリコール、プロピレングリコール、プロパノール、グリセリン、イソプレングリコール、1,3−プロパンジオール、ペンチレングリコール等の低級脂肪族アルコール、酢酸エチル、アセトン、クロロホルム、n−ヘキサンなどの水に相溶性のある有機溶媒が挙げられる。これら有機溶媒は二種以上を混合して用いることもできる。また、含水の有機溶媒を用いる場合には、有機溶媒の含有量は、0体積%超〜100体積%未満の範囲であり得るが、10体積%以上であることが好ましく、10〜80体積%であることがより好ましく、20〜70体積%が更により好ましく、30〜50体積%が特に好ましい。また、その抽出にエタノール又は含水エタノールを用いる場合には、エタノール含量10体積%以上の含水エタノールが好ましく、エタノール含量10〜80体積%の含水エタノールがより好ましく、エタノール含量20〜70体積%の含水エタノールが更により好ましく、エタノール含量30〜50体積%の含水エタノールが特に好ましい。 In the present invention, an extract is prepared based on the above plant and used as an active ingredient. More specifically, chromomy extract, which is an extract of chromomy, is used as the above-mentioned functional component. As an extraction solvent used for the extraction, an appropriate solvent may be used as appropriate. Typically, water, an organic solvent, or a water-containing organic solvent is used. Examples of the organic solvent include, for example, methanol, ethanol, 1,3-butylene glycol, propylene glycol, propanol, glycerin, isoprene glycol, 1,3-propanediol, pentylene glycol and other lower aliphatic alcohols, ethyl acetate. Organic solvents compatible with water, such as acetone, chloroform, and n-hexane. These organic solvents can be used in combination of two or more. When a water-containing organic solvent is used, the content of the organic solvent can be in the range of more than 0% by volume to less than 100% by volume, but is preferably 10% by volume or more, preferably 10 to 80% by volume. Is more preferable, 20-70 volume% is still more preferable, and 30-50 volume% is especially preferable. When ethanol or hydrous ethanol is used for the extraction, hydrous ethanol having an ethanol content of 10% by volume or more is preferred, hydrous ethanol having an ethanol content of 10 to 80% by volume is more preferred, and hydrous ethanol having an ethanol content of 20 to 70% by volume. Ethanol is even more preferable, and hydrous ethanol having an ethanol content of 30 to 50% by volume is particularly preferable.
抽出の具体的手法としては、一般的な抽出手段を採用することができ、例えば、クロモジの幹枝の乾燥物を適当に裁断した後、その全質量に対して1〜50倍、好ましくは5〜20倍量の抽出溶媒を加え、1〜24時間程度、室温〜使用溶媒の沸点の範囲で浸漬・加熱抽出を行うことができる。必要に応じて、加圧下に抽出を行ってもよい。抽出後には、必要に応じて濾過を行ったり、得られた抽出液を減圧濃縮したり、凍結乾燥したりして、溶媒を除去したりしてもよく、適宜目的とする抽出物を調製することができる。乾燥手段としては、減圧乾燥や噴霧乾燥であってもよい。なお、例えば、抽出溶媒が水である場合には、抽出温度は5〜100℃であることが好ましく、30〜100℃であることがより好ましく、50〜100℃であることが更により好ましい。また、抽出溶媒がエタノール又は含水エタノールである場合には、抽出温度は5〜70℃であることが好ましく、30〜70℃であることがより好ましく、50〜70℃であることが更により好ましい。 As a specific method of extraction, a general extraction means can be employed, for example, after appropriately cutting a dried product of the trunk branch of black moji, 1 to 50 times, preferably 5 to 5 times its total mass. A 20-fold amount of extraction solvent is added, and immersion and heating extraction can be performed in the range of room temperature to the boiling point of the solvent used for about 1 to 24 hours. If necessary, extraction may be performed under pressure. After extraction, filtration may be performed as necessary, the obtained extract may be concentrated under reduced pressure, or lyophilized to remove the solvent, and the target extract is appropriately prepared. be able to. The drying means may be reduced pressure drying or spray drying. For example, when the extraction solvent is water, the extraction temperature is preferably 5 to 100 ° C, more preferably 30 to 100 ° C, and still more preferably 50 to 100 ° C. When the extraction solvent is ethanol or hydrous ethanol, the extraction temperature is preferably 5 to 70 ° C, more preferably 30 to 70 ° C, and still more preferably 50 to 70 ° C. .
上記のようにして得られたクロモジエキスは、後述の実施例で示されるように、コラゲナーゼやエラスターゼの活性を阻害する効果に優れている。よって、これを生体に作用させることにより、肌のハリ又はうるおいを改善するのに、効果的に用いられ得る。なお、「改善」とは、本発明による組成物を適用しない場合に比べて、適用したほうが肌のハリ又はうるおいの状態を適用者にとってより良い状態にさせることを意味するともに、日頃からそのようなより良い状態を崩さずに維持するための予防的適用をも含む意味である。 The chromophore extract obtained as described above is excellent in the effect of inhibiting the activities of collagenase and elastase, as shown in Examples described later. Therefore, it can be effectively used to improve the elasticity or moisture of the skin by acting on the living body. “Improvement” means that applying the composition according to the present invention makes the skin firmer or moistened to a better state for the applicator as compared to not applying the composition according to the present invention. It also includes preventive application to maintain a better state without breaking it.
本発明による組成物は、例えば皮膚外用等、非経口的に投与されるものであってよい。そのための形態としては、特に制限はなく、溶液、乳液の形態や、分散剤、懸濁剤、安定剤などを添加した形態や、パップ剤、ローション剤、軟膏剤、チンキ剤、クリーム剤等の形態で用いることができる。 The composition according to the present invention may be administered parenterally, for example, for external use on the skin. The form for that is not particularly limited, such as a solution, an emulsion, a form added with a dispersant, a suspension, a stabilizer, a poultice, a lotion, an ointment, a tincture, a cream, etc. It can be used in the form.
一方、本発明による組成物は、例えば、経口的に投与されるものであってよい。経口投与のための形態としては、特に制限はなく、上記に説明したクロモジエキスと、経口摂取用として許容される基材や担体、溶媒等を用いて、固体状物、液状物、乳化状物、ペースト状物、ゼリー状物等の形態とすることができる。また、錠剤、顆粒剤、散剤、液剤、カプセル剤等の形態とすることができる。また、上記に説明したクロモジエキスを適当な担体、好ましくは脂肪酸トリグリセライドと混合し、液状のままソフトカプセル等に充填し、調製することもできる。 On the other hand, the composition according to the present invention may be administered orally, for example. The form for oral administration is not particularly limited, and the solid form, liquid form, emulsion form using the above-described chromomy extract and a base material, carrier, solvent, etc. that are acceptable for oral intake. It can be in the form of a paste, jelly, or the like. Moreover, it can be set as forms, such as a tablet, a granule, a powder, a liquid agent, a capsule. Alternatively, the above-described chromodi extract can be mixed with an appropriate carrier, preferably a fatty acid triglyceride, and filled in a soft capsule or the like in a liquid state.
製剤化においては、非経口剤や経口剤となす場合に限られず、必要に応じて、通常使用されている賦形剤、結合剤、崩壊剤、滑沢剤、安定剤、界面活性剤、溶解補助剤、還元剤、緩衝剤、吸着剤、流動化剤、帯電防止剤、抗酸化剤、甘味剤、矯味剤、清涼化剤、遮光剤、着香剤、香料、芳香剤、コーティング剤、可塑剤等の製剤添加物の1種または2種以上を適宜選択して添加してもよい。 Formulation is not limited to parenteral or oral preparations, and if necessary, commonly used excipients, binders, disintegrants, lubricants, stabilizers, surfactants, dissolution agents Auxiliary agent, reducing agent, buffering agent, adsorbent, fluidizer, antistatic agent, antioxidant, sweetener, corrigent, cooling agent, sunscreen agent, flavoring agent, fragrance, fragrance, coating agent, plastic One or more preparation additives such as an agent may be appropriately selected and added.
そのような製剤添加物としては、具体的には、例えば、結晶セルロース、低置換度ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、クロスカルメロースナトリウム、マルトデキストリン、エチルセルロース、乳糖、ソルビトール、無水ケイ酸、ケイ酸マグネシウム、ヒドロキシプロピルセルロース、ステアリン酸、オレイン酸、流動パラフィン、第二リン酸カルシウム、セバチン酸ジブチル、マクロゴール、プロピレングリコール、コーンスターチ、デンプン、アルファー化デンプン、ゼラチン、ポピドン、クロスポピドン、グリセリン、ポリソルベート80、クエン酸、アセスルファムカリウム、アスパルテーム、炭酸ナトリウム、タルク、ステアリン酸マグネシウム、ステアリン酸カルシウム等を挙げることができる。 Specific examples of such formulation additives include crystalline cellulose, low-substituted hydroxypropylcellulose, hydroxypropylmethylcellulose, croscarmellose sodium, maltodextrin, ethylcellulose, lactose, sorbitol, silicic anhydride, and silicic acid. Magnesium, hydroxypropyl cellulose, stearic acid, oleic acid, liquid paraffin, dicalcium phosphate, dibutyl sebacate, macrogol, propylene glycol, corn starch, starch, pregelatinized starch, gelatin, popidone, crospovidone, glycerin, polysorbate 80, citrus Acid, acesulfame potassium, aspartame, sodium carbonate, talc, magnesium stearate, calcium stearate, etc. That.
本発明による肌のハリ又はうるおいの改善用組成物においては、上記に説明したクロモジエキスを有効成分とし、更に、ビタミン、ミネラル、アミノ酸、脂肪酸、食物繊維等の他の成分を添加してもよい。 In the composition for improving skin firmness or moisture according to the present invention, the above-described chromomy extract may be used as an active ingredient, and other ingredients such as vitamins, minerals, amino acids, fatty acids, and dietary fibers may be added. .
本発明による肌のハリ又はうるおいの改善用組成物においては、有効成分たる上記クロモジエキスを全体中に乾燥分換算で0.001〜99質量%含有していることが好ましく、0.01〜70質量%含有していることがより好ましく、0.05〜50質量%含有していることが更により好ましい。 In the composition for improving the firmness or moisture of the skin according to the present invention, it is preferable to contain 0.001 to 99% by mass of the above-mentioned chromodi extract as an active ingredient in terms of dry matter, and 0.01 to 70%. More preferably, it is contained in an amount of 0.05 to 50% by mass.
本発明による肌のハリ又はうるおいの改善用組成物をヒトに外用の形態で用いる場合、その施与・塗布量としては、例えば、上記に説明したクロモジエキスの乾燥分換算で塗布面積あたりに0.01〜10mg/cm2程度であることが好ましく、0.05〜5mg/cm2程度であることがより好ましい。また、経口投与する場合、その投与量としては、年齢や体重によっても異なるが、例えば、成人1日当たり、上記に説明したクロモジエキスの乾燥分換算で1.0mg〜50g程度であることが好ましく、5.0mg〜20g程度であることがより好ましく、10mg〜10g程度であることが更により好ましい。 When the composition for improving skin firmness or moisture according to the present invention is used in a form for external use by humans, the amount applied / applied is, for example, 0 per application area in terms of dry matter of the above-described chromomy extract. is preferably .01~10mg / cm 2 or so, more preferably about 0.05 to 5 mg / cm 2. In addition, when orally administered, the dose varies depending on the age and body weight, but for example, it is preferably about 1.0 mg to 50 g per day for an adult, in terms of dry matter of the above-described chromomy extract, More preferably, it is about 5.0 mg to 20 g, and still more preferably about 10 mg to 10 g.
本発明による肌のハリ又はうるおいの改善用組成物の使用形態としては、特に制限はない。例えば、化粧品、医薬部外品、サプリメント、機能性食品、医薬品などの形態であってよい。なお、これらの形態は、ヒト用だけに限られず、動物用であってもよい。より具体的には、化粧品、医薬部外品、サプリメント、機能性表示食品、特定保健用食品、健康食品、機能性食品、栄養補助食品、医薬品、動物用化粧品、動物用医薬部外品、動物用サプリメント、動物用健康食品、動物用機能性食品、動物用栄養補助食品、動物用医薬品など各種の製品形態で使用されることが可能であり、あるいはそれら製品と組み合わせて使用されることが可能である。 There is no restriction | limiting in particular as a usage form of the composition for skin firmness or moisture improvement by this invention. For example, it may be in the form of cosmetics, quasi drugs, supplements, functional foods, pharmaceuticals, and the like. These forms are not limited to human use, and may be animal use. More specifically, cosmetics, quasi-drugs, supplements, functional labeling foods, foods for specified health use, health foods, functional foods, nutritional supplements, pharmaceuticals, veterinary cosmetics, quasi-drugs for animals, animals Can be used in various product forms such as supplements for animals, health foods for animals, functional foods for animals, nutritional supplements for animals, veterinary drugs, etc., or can be used in combination with these products It is.
本発明による肌のハリ又はうるおいの改善用組成物の使用形態としては、化粧料組成物の形態であってもよい。すなわち、上記に説明したクロモジエキスを化粧料に所定量配合することにより、所定の機能性を発揮させるための化粧料組成物となすことができる。具体的には、例えば、乳液、石鹸、洗顔料、入浴剤、クリーム、化粧水、日焼け・日焼け止めローション、パック、シャンプー、リンス、トリートメント、洗浄料等が挙げられる。 The use form of the composition for improving skin firmness or moisture according to the present invention may be in the form of a cosmetic composition. That is, it can be set as the cosmetic composition for exhibiting a predetermined | prescribed functionality by mix | blending predetermined amount with the chromomy extract demonstrated above in cosmetics. Specific examples include emulsions, soaps, facial cleansers, bath additives, creams, skin lotions, suntan / sunscreen lotions, packs, shampoos, rinses, treatments, cleaning agents, and the like.
本発明による肌のハリ又はうるおいの改善用組成物の使用形態としては、食品組成物の形態であってもよい。すなわち、上記に説明したクロモジエキスを飲食物に所定量配合することにより、所定の機能性を発揮させるための食品組成物と成すことができる。具体的には、例えば、固形状、粉末状、顆粒状のものとしては、ビスケット、クッキー、ケーキ、スナック、煎餅などの各種の菓子類、パン、粉末飲料(粉末コーヒー、粉末ココアなど)、飴、キャラメル等を挙げることができるが、これらに限定されるものではない。また、液状、乳化状、ペースト状、ゼリー状のものとしては、ドリンク、ゼリー、ムースなどの各種製品や薬用酒等を挙げることができるが、これらに限定されるものではない。更には、これら飲食物に配合するために用いられる食品添加用の組成物の形態であってもよい。 The use form of the composition for improving skin firmness or moisture according to the present invention may be in the form of a food composition. That is, it can be made into a food composition for exhibiting a predetermined functionality by blending a predetermined amount of the above-described black moji extract into food and drink. Specifically, for example, as solid, powder, granule, various confectionery such as biscuits, cookies, cakes, snacks, rice crackers, bread, powdered beverages (powdered coffee, powdered cocoa, etc.), rice cakes , Caramel and the like, but are not limited thereto. Examples of liquid, emulsified, pasty, and jelly-like products include various products such as drinks, jelly, and mousse, and medicinal liquors, but are not limited thereto. Furthermore, the form of the composition for food addition used in order to mix | blend with these food and drink may be sufficient.
以下に実施例を挙げて本発明について更に具体的に説明するが、これらの実施例は本発明の範囲を限定するものではない。 EXAMPLES The present invention will be described more specifically with reference to the following examples. However, these examples do not limit the scope of the present invention.
[調製例1](熱水抽出物 ロット1)
クロモジ(Lindera umbellata Thunb.)の幹枝の乾燥物を裁断した後、その全量の10倍量の水を加えて加熱し、沸騰後1時間、浸漬・加熱抽出を行った。抽出後は濾過により不溶物を除き、得られた濾液を減圧濃縮後、凍結乾燥にて溶媒を除去して、乾燥粉末状のクロモジエキス末を得た。
[Preparation Example 1] (Hot water extract lot 1)
After cutting the dried material of the trunk branches of black moji (Lindera umbellata Thunb.), 10 times the total amount of water was added and heated, followed by immersion and heat extraction for 1 hour after boiling. After extraction, insoluble matters were removed by filtration, and the obtained filtrate was concentrated under reduced pressure, and then the solvent was removed by lyophilization to obtain a dry powdery cromozi extract powder.
[調製例2](熱水抽出物 ロット2)
クロモジ(Lindera umbellata Thunb.)の幹枝の乾燥物を裁断した後、その全量の10倍量の水を加えて加熱し、沸騰後1時間、浸漬・加熱抽出を行った。抽出後に濾過し、得られた濾液の一部を抽出液試料とし、残りを減圧乾固して溶媒を除去し、乾燥粉末状のクロモジエキス末を得た。
[Preparation Example 2] (Hot water extract lot 2)
After cutting the dried material of the trunk branches of black moji (Lindera umbellata Thunb.), 10 times the total amount of water was added and heated, followed by immersion and heat extraction for 1 hour after boiling. After extraction, a portion of the obtained filtrate was used as an extract sample, and the rest was dried under reduced pressure to remove the solvent, thereby obtaining a dry powdered chromodi extract powder.
[調製例3](30%エタノール抽出物(室温、1週間))
クロモジ(Lindera umbellata Thunb.)の幹枝の乾燥物を裁断した後、その全量の5倍量の30%エタノール/70%水−混合液を加え、室温に1週間静置して抽出を行った。抽出後に濾過し、得られた濾液を減圧乾固して溶媒を除去し、乾燥粉末状のクロモジエキス末を得た。
[Preparation Example 3] (30% ethanol extract (room temperature, 1 week))
After cutting the dried product of the trunk branch of black moji (Lindera umbellata Thunb.), 5 times its total amount of 30% ethanol / 70% water-mixture was added, and the mixture was allowed to stand at room temperature for 1 week for extraction. It filtered after extraction, the obtained filtrate was dried under reduced pressure, the solvent was removed, and the dry powder-like chromodi extract powder was obtained.
[調製例4](30%エタノール抽出物(60℃、3時間))
クロモジ(Lindera umbellata Thunb.)の幹枝の乾燥物を裁断した後、その全量の5倍量の30%エタノール/70%水−混合液を加え、60℃で3時間抽出を行った。抽出後に濾過し、得られた濾液を減圧乾固して溶媒を除去し、乾燥粉末状のクロモジエキス末を得た。
[Preparation Example 4] (30% ethanol extract (60 ° C., 3 hours))
After cutting the dried material of the trunk branches of black moji (Lindera umbellata Thunb.), 5 times its total amount of 30% ethanol / 70% water-mixture was added, and extraction was performed at 60 ° C. for 3 hours. It filtered after extraction, the obtained filtrate was dried under reduced pressure, the solvent was removed, and the dry powder-like chromodi extract powder was obtained.
[調製例5](50%エタノール抽出物(60℃、3時間))
クロモジ(Lindera umbellata Thunb.)の幹枝の乾燥物を裁断した後、その全量の5倍量の50%エタノール/50%水−混合液を加え、60℃で3時間抽出を行った。抽出後に濾過し、得られた濾液を減圧乾固して溶媒を除去し、乾燥粉末状のクロモジエキス末を得た。
[Preparation Example 5] (50% ethanol extract (60 ° C., 3 hours))
After cutting the dried product of the trunk branches of black moji (Lindera umbellata Thunb.), 5 times its total amount of 50% ethanol / 50% water-mixture was added, and extraction was performed at 60 ° C. for 3 hours. It filtered after extraction, the obtained filtrate was dried under reduced pressure, the solvent was removed, and the dry powder-like chromodi extract powder was obtained.
[調製例6](100%エタノール抽出物)
クロモジ(Lindera umbellata Thunb.)の幹枝の乾燥物を裁断した後、その全量の5倍量の100%エタノールを加え、室温に1週間静置して抽出を行った。抽出後に濾過し、得られた濾液の一部を抽出液試料とし、残りを減圧乾固して溶媒を除去し、乾燥粉末状のクロモジエキス末を得た。
[Preparation Example 6] (100% ethanol extract)
After cutting the dried material of the trunk branch of black moji (Lindera umbellata Thunb.), 5 times its total amount of 100% ethanol was added, and the mixture was allowed to stand at room temperature for 1 week for extraction. After extraction, a portion of the obtained filtrate was used as an extract sample, and the rest was dried under reduced pressure to remove the solvent, thereby obtaining a dry powdered chromodi extract powder.
<試験例1>
調製例1で得られたクロモジエキス末(熱水抽出物)を用いて、コラゲナーゼの阻害作用を検証した。
<Test Example 1>
Using the black moji extract powder (hot water extract) obtained in Preparation Example 1, the inhibitory action of collagenase was verified.
評価にはコラゲナーゼアッセイキット(「コラゲノキットCLN-100」、コラーゲン技術研修会)を使用し、上記クロモジエキス末を所定濃度となるよう滅菌蒸留水に溶解して試験サンプルとした。そして、キットに記載の方法に従い、コラゲナーゼ(オタマジャクシ由来)に対し、クロモジエキス末によるコラゲナーゼ阻害活性を評価した。 For the evaluation, a collagenase assay kit (“Colageno Kit CLN-100”, Collagen Technology Workshop) was used, and the above-mentioned chromodi extract powder was dissolved in sterilized distilled water to a predetermined concentration to obtain a test sample. Then, according to the method described in the kit, the collagenase inhibitory activity of the chromophore extract powder was evaluated for collagenase (derived from tadpoles).
具体的には、キットに記載の方法に従い、1unit/mLになるように希釈した酵素液と試験サンプルが9:1になるように混合した検体溶液を調製後、検体溶液100μLと基質溶液(A液:B液=1:1)100μLを混合して35℃で120分間反応させた。その後、反応停止液(C液)5μLを添加して撹拌後、3000rpmで10分間遠心分離した上清を、黒色の96穴マイクロプレートに200μLずつ分注し、マイクロプレートリーダーを用いて、励起波長495nm/蛍光波長520nmにおける蛍光強度を測定した。 Specifically, according to the method described in the kit, after preparing a sample solution in which the enzyme solution diluted to 1 unit / mL and the test sample are mixed at 9: 1, 100 μL of the sample solution and the substrate solution (A Liquid: Liquid B = 1: 1) 100 μL was mixed and reacted at 35 ° C. for 120 minutes. Thereafter, 5 μL of the reaction stop solution (C solution) was added and stirred, and then the supernatant obtained by centrifugation at 3000 rpm for 10 minutes was dispensed 200 μL at a time into a black 96-well microplate, and the excitation wavelength was measured using a microplate reader. The fluorescence intensity at 495 nm / fluorescence wavelength 520 nm was measured.
コラゲナーゼ阻害率は下記式(1)にて算出した。 The collagenase inhibition rate was calculated by the following formula (1).
コラゲナーゼ阻害率(%)=(1−A / B)×100 …(1)
(式(1)中、Aは試験サンプル添加系の蛍光値であり、Bは試験サンプル非添加系の蛍光値(コントロール:全発色)である。)
また、IC50(50%阻害濃度)は、常法に従い、コラゲナーゼ反応系に添加した試験サンプルの濃度とそのときの阻害率の関係性に基づいて算出した。
Collagenase inhibition rate (%) = (1−A / B) × 100 (1)
(In Formula (1), A is the fluorescence value of the test sample addition system, and B is the fluorescence value of the test sample non-addition system (control: total color development).)
IC 50 (50% inhibitory concentration) was calculated based on the relationship between the concentration of the test sample added to the collagenase reaction system and the inhibition rate at that time according to a conventional method.
結果を表1及び図1に示す。 The results are shown in Table 1 and FIG.
その結果、表1及び図1に示されるように、クロモジエキス末(熱水抽出物)は、コラゲナーゼ活性を濃度依存的に阻害した。また、IC50の値は0.029mg/mLであった。 As a result, as shown in Table 1 and FIG. 1, the black moji extract powder (hot water extract) inhibited the collagenase activity in a concentration-dependent manner. The IC 50 value was 0.029 mg / mL.
<試験例2>
調製例1で得られたクロモジエキス末(熱水抽出物)を用いて、エラスターゼの阻害作用を検証した。
<Test Example 2>
Using the black moji extract powder (hot water extract) obtained in Preparation Example 1, the inhibitory action of elastase was verified.
評価にはエラスターゼアッセイキット(「Sensolyte Green Elastase Assay Kit」、AnaSpec社)を使用し、上記クロモジエキス末を所定濃度となるよう滅菌蒸留水に溶解して試験サンプルとした。そして、キットの記載の方法に従い、エラスターゼ(ブタ脾臓由来)に対し、クロモジエキス末によるエラスターゼ阻害活性を評価した。 For the evaluation, an elastase assay kit (“Sensolyte Green Elastase Assay Kit”, AnaSpec) was used, and the above-mentioned chromodi extract powder was dissolved in sterilized distilled water to a predetermined concentration to prepare a test sample. Then, according to the method described in the kit, elastase inhibitory activity by the chromodi extract powder was evaluated for elastase (derived from porcine spleen).
具体的には、キットに記載の方法に従い、黒色の96穴マイクロプレートに試験サンプル10μL、酵素液40μLを入れて撹拌し、37℃で10分間静置した。その後、予め37℃でインキュベートしておいた基質液50μLを添加し、37℃で60分間反応させた。反応液は60分後に励起波長494nm/蛍光波長538nmにおける蛍光強度を測定した。 Specifically, according to the method described in the kit, 10 μL of a test sample and 40 μL of an enzyme solution were placed in a black 96-well microplate, stirred, and allowed to stand at 37 ° C. for 10 minutes. Thereafter, 50 μL of a substrate solution previously incubated at 37 ° C. was added and reacted at 37 ° C. for 60 minutes. After 60 minutes, the reaction solution was measured for fluorescence intensity at an excitation wavelength of 494 nm / fluorescence wavelength of 538 nm.
エラスターゼ阻害率は下記式(2)にて算出した。 The elastase inhibition rate was calculated by the following formula (2).
エラスターゼ阻害率(%)=(1−A / B)×100 …(2)
(式(2)中、Aは試験サンプル添加系の蛍光値であり、Bは試験サンプル非添加系の蛍光値(コントロール:全発色)である。)
Elastase inhibition rate (%) = (1−A / B) × 100 (2)
(In Formula (2), A is the fluorescence value of the test sample addition system, and B is the fluorescence value of the test sample non-addition system (control: total color development).)
結果を表2及び図2に示す。 The results are shown in Table 2 and FIG.
その結果、表2及び図2に示されるように、クロモジエキス末(熱水抽出物)は、エラスターゼ活性を濃度依存的に阻害した。 As a result, as shown in Table 2 and FIG. 2, the black moji extract powder (hot water extract) inhibited the elastase activity in a concentration-dependent manner.
<試験例3>
調製例2〜6で得られたクロモジ抽出液又はエキス末を用いて、コラゲナーゼの阻害作用を検証した。試験は、コラゲナーゼ(オタマジャクシ由来)をコラゲナーゼ(E.coli由来組換)に代えた以外は、試験例1と同様にして行った。
<Test Example 3>
The inhibitory action of collagenase was verified using the chromophore extract or extract powder obtained in Preparation Examples 2-6. The test was conducted in the same manner as in Test Example 1 except that collagenase (derived from tadpole) was replaced with collagenase (recombinant derived from E. coli).
結果を表3に示す。なお、表3には、調製例2〜6においてクロモジ抽出液又はエキス末を調製したときの収率についても、併せて示した。 The results are shown in Table 3. Table 3 also shows the yields when the chromomy extract or extract powder was prepared in Preparation Examples 2-6.
その結果、表3に示されるように、エタノール又は含水エタノールによる抽出でも、クロモジエキスは、コラゲナーゼ活性を濃度依存的に阻害した。また、IC50の値からも分かるように、同じ反応濃度で比べると、クロモジエキスは、エタノール又は含水エタノールによる抽出のほうが、熱水抽出に比べて、コラゲナーゼに対する阻害活性がより顕著であった。 As a result, as shown in Table 3, even with extraction with ethanol or water-containing ethanol, chromomy extract inhibited collagenase activity in a concentration-dependent manner. In addition, as can be seen from the IC 50 value, when compared with the same reaction concentration, the chromomy extract was more markedly inhibited by collagen or hydrous ethanol than the hot water extraction.
<試験例4>
調製例2〜6と同様にして別ロットで得られたクロモジ抽出液又はエキス末を用いて、エラスターゼの阻害作用を検証した。試験は、試験例1同様にIC50(50%阻害濃度)を算出した以外は、試験例2と同様にして行った。
<Test Example 4>
In the same manner as in Preparation Examples 2 to 6, the inhibitory action of elastase was verified using a chromophore extract or extract powder obtained in another lot. The test was conducted in the same manner as in Test Example 2 except that IC 50 (50% inhibitory concentration) was calculated as in Test Example 1.
結果を表4に示す。 The results are shown in Table 4.
その結果、表4に示されるように、エタノール又は含水エタノールによる抽出でも、クロモジエキスは、エラスターゼ活性を濃度依存的に阻害した。また、IC50の値からも分かるように、同じ反応濃度で比べると、クロモジエキスは、エタノール又は含水エタノールによる抽出のほうが、熱水抽出に比べて、エラスターゼに対する阻害活性がより顕著であった。 As a result, as shown in Table 4, even with extraction with ethanol or hydrous ethanol, chromodi extract inhibited the elastase activity in a concentration-dependent manner. Further, as can be seen from the IC 50 value, when compared with the same reaction concentration, the chromomy extract was more markedly inhibited by elastase or hydrous ethanol than the hot water extraction.
(処方例1)
以下に示す組成でクロモジエキスを含有するエモリエントクリームを調製した。
(1)エモリエントクリーム:
(組成) (重量部)
ミツロウ 2.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクアラン 10.0
自己乳化型プロピレングリコール 3.0
モノステアレートポリオキシエチレン
セチルエーテル(20EO) 1.0
香料 0.5
酸化防止剤 微量
防腐剤 微量
プロピレングリコール 4.8
グリセリン 3.0
ヒアロルン酸ナトリウム 0.1
調製例1のクロモジエキス末 0.1
トリエタノールアミン 1.0
精製水 61.5
全量 100.0
(Prescription Example 1)
An emollient cream containing a black moji extract with the following composition was prepared.
(1) Emollient cream:
(Composition) (Parts by weight)
Beeswax 2.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying propylene glycol 3.0
Monostearate polyoxyethylene cetyl ether (20EO) 1.0
Fragrance 0.5
Antioxidant Trace amount of preservative Trace amount of propylene glycol 4.8
Glycerin 3.0
Sodium hyaluronate 0.1
Chromoji extract powder of Preparation Example 0.1
Triethanolamine 1.0
Purified water 61.5
Total amount 100.0
(処方例2)
以下に示す組成でクロモジエキスを含有する乳液状ファンデーションを調製した。
(2)乳液状ファンデーション:
(組成) (重量部)
ステアリン酸 2.4
モノステアリン酸プロピレングリコール 2.0
セトステアリルアルコール 0.2
液状ラノリン 2.0
流動パラフィン 3.0
ミリスチン酸イソプロピル 8.5
パラオキシ安息香酸プロピル 微量
精製水 64.1
カルボキシメチルセルロースナトリウム 0.2
ベントナイト 0.5
プロピレングリコール 3.8
ヒアロルン酸ナトリウム 0.1
調製例1のクロモジエキス末 0.1
トリエタノールアミン 1.1
パラオキシ安息香酸メチル 微量
酸化チタン 8.0
タルク 4.0
着色含量 微量
香料 微量
スクアラン 10.0
全量 100.0
(Prescription example 2)
An emulsion foundation containing a black moji extract with the composition shown below was prepared.
(2) Emulsion foundation:
(Composition) (Parts by weight)
Stearic acid 2.4
Propylene glycol monostearate 2.0
Cetostearyl alcohol 0.2
Liquid lanolin 2.0
Liquid paraffin 3.0
Isopropyl myristate 8.5
Propyl paraoxybenzoate Trace purified water 64.1
Sodium carboxymethylcellulose 0.2
Bentonite 0.5
Propylene glycol 3.8
Sodium hyaluronate 0.1
Chromoji extract powder of Preparation Example 0.1
Triethanolamine 1.1
Methyl parahydroxybenzoate Trace amount of titanium oxide 8.0
Talc 4.0
Coloring content Trace fragrance Trace squalane 10.0
Total amount 100.0
(処方例3)
以下に示す組成でクロモジエキスを含有する飴を調製した。
(3)飴:
(組成) (重量部)
粉末ソルビトール 89.70
香料 0.25
調製例1のクロモジエキス末 10.00
ソルビトールシード 0.05
全量 100.00
(Prescription Example 3)
A cocoon extract containing chromomy extract was prepared with the composition shown below.
(3) 飴:
(Composition) (Parts by weight)
Powdered sorbitol 89.70
Fragrance 0.25
Chromoji extract powder of Preparation Example 10.00
Sorbitol seed 0.05
Total amount 100.00
(処方例4)
以下に示す組成でクロモジエキスを含有するガムを調製した。
(4)ガム:
(組成) (重量部)
ガムベース 20.00
炭酸カルシウム 2.00
ステビオサイド 0.10
調製例1のクロモジエキス末 10.00
乳糖 66.90
香料 1.00
全量 100.00
(Prescription Example 4)
A gum containing a chromodis extract having the composition shown below was prepared.
(4) Gum:
(Composition) (Parts by weight)
Gum base 20.00
Calcium carbonate 2.00
Stevioside 0.10
Chromoji extract powder of Preparation Example 10.00
Lactose 66.90
Fragrance 1.00
Total amount 100.00
(処方例5)
以下に示す組成でクロモジエキスを含有するキャラメルを調製した。
(5)キャラメル:
(組成) (重量部)
グラニュー糖 32.00
水飴 20.00
粉乳 30.00
硬化油 4.00
食塩 0.60
香料 0.03
水 3.37
調製例1のクロモジエキス末 10.00
全量 100.00
(Prescription Example 5)
A caramel containing a black moji extract with the composition shown below was prepared.
(5) Caramel:
(Composition) (Parts by weight)
Granulated sugar 32.00
Minamata 20.00
Milk powder 30.00
Hardened oil 4.00
Salt 0.60
Perfume 0.03
Water 3.37
Chromoji extract powder of Preparation Example 10.00
Total amount 100.00
(処方例6)
以下に示す組成でクロモジエキスを含有する炭酸飲料を調製した。
(6)炭酸飲料:
(組成) (重量部)
グラニュー糖 8.00
濃縮レモン果汁 1.00
L−アスコルビン酸 0.10
クエン酸 0.09
クエン酸ナトリウム 0.05
着色料 0.05
炭酸水 80.71
調製例1のクロモジエキス末 10.00
全量 100.00
(Prescription Example 6)
A carbonated beverage containing chromomy extract with the composition shown below was prepared.
(6) Carbonated drink:
(Composition) (Parts by weight)
Granulated sugar 8.00
Concentrated lemon juice 1.00
L-ascorbic acid 0.10
Citric acid 0.09
Sodium citrate 0.05
Coloring agent 0.05
Carbonated water 80.71
Chromoji extract powder of Preparation Example 10.00
Total amount 100.00
(処方例7)
以下に示す組成でクロモジエキスを含有するジュースを調製した。
(7)ジュース:
(組成) (重量部)
冷凍濃縮オレンジ果汁 5.00
果糖ブドウ糖液糖 1.00
クエン酸 0.10
L−アスコルビン酸 0.09
調製例1のクロモジエキス末 10.00
香料 0.20
色素 0.10
水 83.51
全量 100.00
(Prescription Example 7)
Juice containing chromomy extract with the composition shown below was prepared.
(7) Juice:
(Composition) (Parts by weight)
Frozen concentrated orange juice 5.00
Fructose glucose liquid sugar 1.00
Citric acid 0.10
L-ascorbic acid 0.09
Chromoji extract powder of Preparation Example 10.00
Fragrance 0.20
Dye 0.10
Water 83.51
Total amount 100.00
(処方例8)
以下に示す組成でクロモジエキスを含有する乳酸菌飲料を調製した。
(8)乳酸菌飲料:
(組成) (重量部)
乳固形21%発酵乳 14.76
果糖ブドウ糖液糖 13.31
ペクチン 0.50
クエン酸 0.08
香料 0.15
水 61.20
調製例1のクロモジエキス末 10.00
全量 100.00
(Prescription Example 8)
A lactic acid bacteria beverage containing a black moji extract with the composition shown below was prepared.
(8) Lactic acid bacteria beverage:
(Composition) (Parts by weight)
Milk solid 21% fermented milk 14.76
Fructose dextrose liquid sugar 13.31
Pectin 0.50
Citric acid 0.08
Fragrance 0.15
Water 61.20
Chromoji extract powder of Preparation Example 10.00
Total amount 100.00
(処方例9)
以下に示す組成でクロモジエキスを含有するアルコール飲料を調製した。
(9)アルコール飲料:
(組成) (重量部)
50%エタノール 32.00
砂糖 8.60
果汁 2.40
調製例1のクロモジエキス末 10.00
水 47.00
全量 100.00
(Prescription Example 9)
An alcoholic beverage containing a black moji extract with the composition shown below was prepared.
(9) Alcoholic beverages:
(Composition) (Parts by weight)
50% ethanol 32.00
Sugar 8.60
Fruit juice 2.40
Chromoji extract powder of Preparation Example 10.00
Water 47.00
Total amount 100.00
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018077655 | 2018-04-13 | ||
JP2018077655 | 2018-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2019182863A true JP2019182863A (en) | 2019-10-24 |
Family
ID=68337918
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019075399A Active JP7328670B2 (en) | 2018-04-13 | 2019-04-11 | Composition for improving locomotive syndrome |
JP2019075395A Pending JP2019182863A (en) | 2018-04-13 | 2019-04-11 | Skin firmness or moisture improving composition |
JP2023085314A Active JP7385325B2 (en) | 2018-04-13 | 2023-05-24 | Composition for improving locomotive syndrome |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019075399A Active JP7328670B2 (en) | 2018-04-13 | 2019-04-11 | Composition for improving locomotive syndrome |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023085314A Active JP7385325B2 (en) | 2018-04-13 | 2023-05-24 | Composition for improving locomotive syndrome |
Country Status (1)
Country | Link |
---|---|
JP (3) | JP7328670B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6770726B1 (en) * | 2020-01-14 | 2020-10-21 | 国立大学法人 熊本大学 | Preventive or ameliorating agents for metabolic syndrome |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62238207A (en) * | 1986-04-04 | 1987-10-19 | Eikoudou:Kk | Cosmetic |
JP2007038115A (en) * | 2005-08-02 | 2007-02-15 | Dainippon Kasei Kk | Method of extracting biological origin component |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1325681A1 (en) | 2001-12-11 | 2003-07-09 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health |
CN102686547B (en) | 2009-12-25 | 2015-07-22 | 狮王株式会社 | 3,5-dihydroxy-2-menthenyl stilbene,plant extract containing same,method for collecting same,and application for same |
JP7007663B2 (en) * | 2016-11-04 | 2022-02-10 | 高知県公立大学法人 | Kuro-moji extract |
-
2019
- 2019-04-11 JP JP2019075399A patent/JP7328670B2/en active Active
- 2019-04-11 JP JP2019075395A patent/JP2019182863A/en active Pending
-
2023
- 2023-05-24 JP JP2023085314A patent/JP7385325B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62238207A (en) * | 1986-04-04 | 1987-10-19 | Eikoudou:Kk | Cosmetic |
JP2007038115A (en) * | 2005-08-02 | 2007-02-15 | Dainippon Kasei Kk | Method of extracting biological origin component |
Also Published As
Publication number | Publication date |
---|---|
JP2023099723A (en) | 2023-07-13 |
JP7328670B2 (en) | 2023-08-17 |
JP7385325B2 (en) | 2023-11-22 |
JP2019180409A (en) | 2019-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101847013B1 (en) | Composition for enhancing elasticity and whitening | |
US5922324A (en) | Propolis extract with improved water-solubility | |
KR20130132548A (en) | Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same | |
JPWO2005072684A1 (en) | Maca extract manufacturing method | |
KR20130024025A (en) | A anti-inflammatory or skin moisturizing composition containing fermented plant extracts as an active ingredient | |
US20090269424A1 (en) | Peripheral blood flow-improving composition | |
EP0867187B1 (en) | Propolis extract with improved water-solubility | |
JP2002293736A (en) | Maillard reaction inhibitor and composition containing the same | |
KR101609340B1 (en) | Composition comprising mixed herbal mixture extract for improving anti-aging or skin whitening | |
KR101889793B1 (en) | Composition for prevention of hair loss or for promoting hair growth comprising a marine animal fermentation | |
JPH07119176B2 (en) | Anti-active oxygen acting composition and anti-active oxygen agent containing the same as an active ingredient, food, cosmetics and pharmaceuticals | |
JP2011195531A (en) | Protein glycation inhibitor | |
KR102371417B1 (en) | Composition for anti inflammation comprising extract of ginseng floral axis | |
KR102228257B1 (en) | Composition for anti-inflammation or anti-acne comprising extract of Immature Citrus Fruit, Curcuma longa and citrus blossom honey | |
JP2004159563A (en) | Propolis composition | |
JP7385325B2 (en) | Composition for improving locomotive syndrome | |
KR101004361B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
JP6122200B1 (en) | Anti-glycation composition | |
KR100478021B1 (en) | Water Soluble Improved Propolis Extract | |
KR101579500B1 (en) | Skin whitening composition comprising an extract obtained from roots of coix lachryma-jobi var. mayuen | |
KR102212343B1 (en) | Composition for skin anti-aging or moisturization comprising extract of marian plum | |
KR101661423B1 (en) | anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method | |
JP7290883B2 (en) | Sweet Potato Extract, α-Glucosidase Inhibitor, and Antioxidant | |
JP2019210278A (en) | Composition for reducing cholesterol, and method for imparting cholesterol reducing functionality | |
KR102334192B1 (en) | Functional cosmetic composition comprising korean dandelion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220323 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20220323 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230322 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230516 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230530 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230516 |